19950305
 Immune Response's Stock Sinks 19% As Partner Quits   By By Rhonda L. Rundle, The Wall Street Journal,  Mar 6, 1995  Shares of Immune Response Corp. plunged 19%, or 81.3 cents, to $3.562 in Nasdaq Stock Market trading Friday, after the company's partner, Rhone-Poulenc Rorer Inc., withdrew from a joint venture to develop a vaccine against human immunodeficiency virus infection.  Immune Response said Friday that it plans to continue testing of the proposed HIV vaccine. But Rhone-Poulenc Rorer said it won't contribute additional funds for the project.   
